tradingkey.logo

Acrivon Therapeutics Inc

ACRV
2.160USD
-0.100-4.42%
Close 12/19, 16:00ETQuotes delayed by 15 min
68.15MMarket Cap
LossP/E TTM

Acrivon Therapeutics Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-2.38
12.84%
Analyst Rating
BUY
2025-12-09

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.

What is the Earnings Per Share (EPS) of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.384, with a year-on-year change of 12.84%.

What is the net income of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its net income was -80.56M, with a year-on-year change of -33.40%.

What is the net margin of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.

What is the gross margin of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.

What is the debt-to-asset ratio of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.

What is the Return on Equity (ROE) of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -54.07%, with a year-on-year change of -30.57%.

What is the Return on Assets (ROA) of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -48.11%, with a year-on-year change of -27.28%.

What is the operating profit of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its operating profit was -89.20M, with a year-on-year change of -32.93%.

What are the current assets of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its current assets were 181.63M, with a year-on-year change of 40.05%.

What are the total assets of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its total assets of Acrivon Therapeutics Inc were 196.59M, with a year-on-year change of 42.18%.

What are the total liabilities of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its total liabilities of Acrivon Therapeutics Inc were 19.80M, with a year-on-year change of 16.00%.

What is the total equity of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its total equity of Acrivon Therapeutics Inc was 176.79M, with a year-on-year change of 45.87%.

What is the net operating income of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its net operating income of Acrivon Therapeutics Inc was -80.56M, with a year-on-year change of -33.40%.

What is the net investment of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its net investment of Acrivon Therapeutics Inc was -51.77M, with a year-on-year change of -202.08%.

What is the net financing of Acrivon Therapeutics Inc?

According to Acrivon Therapeutics Inc's FY2024 earnings report, its net financing of Acrivon Therapeutics Inc was 121.03M, with a year-on-year change of 7888.10%.
KeyAI